New advances in cancer viral immunotherapy

Researchers have developed a new strain of vaccinia virus, which can replicate in tumor cells while maintaining increased immunogenicity. Specifically, it can to induce so-called immunogenic cell death in tumor cells.

Related Keywords

Munich ,Bayern ,Germany ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Spanish ,Juanj Rojas , ,Research Agency ,Bellvitge Biomedical Research Institute ,Health Sciences ,Spanish Association Against Cancer ,University Of Barcelona ,University Of Munich Germany ,Molecular Therapy ,State Research Agency ,